Printer Friendly

Browse Nausea topic

Reports subtopic

Articles

1-24 out of 24 article(s)
Title Author Type Date Words
Middleton's Morning Sickness May Be Genetic. Medical condition overview Mar 22, 2018 366
2017 Global Chemotherapy Induced Nausea and Vomiting Industry Growth, Demand and Insight Research Re. Apr 24, 2017 631
Enhanced recovery in orthopedics: a prospective audit of an enhanced recovery program for patients undergoing hip or knee arthroplasty. Brennan, Catherine; Parsons, Gail Mar 1, 2017 4370
Heron Therapeutics reports inclusion of SUSTOL injection under NCCN Antiemesis Guidelines. Feb 27, 2017 261
Heron Therapeutics reports inclusion of SUSTOL injection under NCCN Antiemesis Guidelines. Feb 27, 2017 257
Chemotherapy-induced Nausea and Vomiting Market Expected to Reach USD 2.659bn by 2022, Allied Market Research Predicts. Jan 30, 2017 393
Chemotherapy-Induced Nausea and Vomiting Drugs Market USD 1.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.. Oct 26, 2016 517
New Report Available: Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015. Report Feb 1, 2016 540
"Nausea - Pipeline Review, H2 2015" Published. Oct 30, 2015 485
Report Published: "Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2015". Oct 11, 2015 485
New Study: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019. Sep 11, 2015 620
"Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2014" Published. Dec 22, 2014 428
Disabilities and doobies: according to the American College of Physicians (ACP)--the nation's second largest doctors' organization after the American Medical Association (AMA)--marijuana is also effective in treating AIDS symptons, glaucoma, as well as the nausea and vomiting that frequently accompany chemotherapy treatments. Levinson, Jerry May 1, 2014 864
"Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013" Published. Oct 30, 2013 427
New market study, "Nausea - Pipeline Review, H2 2013", has been published. Aug 6, 2013 448
Across All Cancer Types, Surveyed U.S. Oncologists Report that 69 Percent of Patients Will Receive Either Highly Emetogenic Chemotherapy or Moderately Emetogenic Chemotherapy. Dec 6, 2012 546
Research and Markets: CINV Existing & Pipeline Drugs (Aloxi, Emend, Netupitant-Palonosetron Fdc, Apf530 & Rolapitant) - Global Market Opportunity Assessment Study, 2012 - 2018. Industry overview Nov 28, 2012 395
Largest Study of Its Kind Shows That Health Plans and Physicians Need to Do More to Combat Nausea and Vomiting During Pregnancy. Report May 7, 2012 985
Post-anesthetic discharge scoring criteria. Dec 1, 2011 2234
LifeSci Advisors Announces Investment Opinion on A.P. Pharma Inc. Aug 29, 2011 860
Research and Markets: Nausea and Vomiting Therapy Area Pipeline Report. Report Jan 21, 2011 411
Fatigue issues dominate outpatient cancer care: in a sample of 3, 123 patients, sleep disturbance and drowsiness were more prevalent than nausea. Birk, Susan Report Nov 15, 2010 808
Preventing postoperative nausea and vomiting: is the answer in your hands? Collins, Angela Smith Report Mar 22, 2010 396
USA research nausea reduction--risk counselling. Dobie, Monica Jun 1, 2006 209

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters